Heart Failure (HFrEF) — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Non-DHP calcium-channel blocker (e.g., verapamil)
Verapamil and diltiazem have negative inotropic effects and should not be used to treat HFrEF. Disease-modifying therapy is built from renin–angiotensin-system or ARNI treatment, an evidence-based beta-blocker, mineralocorticoid-receptor antagonist and SGLT2 inhibitor as tolerated.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/cardiovascular-conditions